Dow Up0.08% Nasdaq Down0.30%

More On SDI.TO



News & Info


Analyst Coverage


  • Major Holders
  • Insider Transactions
  • Insider Roster


Spectral Diagnostics Inc. (SDI.TO)

0.34 Down 0.02(4.29%) 3:31PM EDT
ProfileGet Profile for:
Spectral Diagnostics Inc.
135-2 The West Mall
Toronto, ON M9C 1C2
Canada - Map
Phone: 416-626-3233
Fax: 416-626-7383

Index Membership:N/A
Industry:Medical Laboratories & Research
Full Time Employees:20

Business Summary 

Spectral Diagnostics Inc. develops and commercializes theranostic treatment for severe sepsis in North America. The company’s products include Endotoxin Activity Assay, a rapid diagnostic test for detection of components of gram negative bacterial cell wall; and Toraymyxin, a therapeutic hemoperfusion device for the treatment of sepsis that removes endotoxin from the bloodstream. It is also involved in the development, production, and marketing of recombinant cardiac proteins, antibodies, and calibrators for use in research and development, as well as in products manufactured by other diagnostic companies. The company was founded in 1991 and is headquartered in Toronto, Canada.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Spectral Diagnostics Inc.

Key Executives 
Dr. Paul M. Walker M.D., Ph.D., F.R.C.S., 65
Chief Exec. Officer, Pres, Director and Member of Disclosure Committee
Mr. Anthony Businskas CA,
Chief Financial Officer, Exec. VP, Sec. and Member of Disclosure Committee
Dr. Gualtiero Guadagni ,
VP of Sales and Marketing
Ms. Debra-Anne M. Foster RN, B.Sc., CCRC,
VP of Clinical Devel.
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in CAD.